Company / Depreciation & Amortization
Tyra Biosciences, Inc. Depreciation & Amortization History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$519.0K
FY2024
5-year range
$47.0K / $519.0K
FY2020-FY2024
Trend
+45.4%
vs FY2023
Sector context
#134 of 168
Health Care
What the data says
Tyra Biosciences, Inc.'s depreciation & amortization of $519,000 is lower than 80% of companies in the Health Care sector (FY2024). Depreciation & Amortization has increased for 4 consecutive years, from $47,000 in FY2020 to $519,000 in FY2024.
Based on SEC 10-K filings.
$519,000 in FY2024 with a 3-year CAGR of +54.8%.
Increased from $296,000 to $519,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +54.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-99.8% below sector average
Key checks
Key Insights
- Tyra Biosciences, Inc.'s depreciation & amortization has grown for 4 consecutive years.
- 3-year CAGR of +54.8%, indicating consistent growth.
- In FY2024, depreciation & amortization increased 45.4% year-over-year.
- Ranks #134 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $519.0K | +45.4% |
| FY2023 | $357.0K | +20.6% |
| FY2022 | $296.0K | +111.4% |
| FY2021 | $140.0K | +197.9% |
| FY2020 | $47.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026